Common Contracts
8 similar Sales Agreement contracts by BioSig Technologies, Inc., Acer Therapeutics Inc., Agenus Inc, others
BIOSIG TECHNOLOGIES, INC. Common Stock (par value $0.001 per share) At-The- Market Issuance Sales AgreementSales Agreement • September 15th, 2023 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
BioSig Technologies, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (the “Agent”), as follows:
At-The-Market Issuance Sales AgreementSales Agreement • August 21st, 2023 • Society Pass Incorporated. • Services-business services, nec • New York
Society Pass Incorporated, a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (the “Agent”), as follows:
BIOSIG TECHNOLOGIES, INC. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • August 18th, 2023 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
BioSig Technologies, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
Common Stock (par value $0.001 per share) Sales AgreementSales Agreement • April 26th, 2022 • Terawulf Inc. • Services-computer processing & data preparation • New York
AVINO SILVER & GOLD MINES LTD. Common Shares (no par value) SALES AGREEMENTSales Agreement • January 13th, 2021 • Avino Silver & Gold Mines LTD • Metal mining • New York
Avino Silver & Gold Mines Ltd. (the “Company”), a company amalgamated under the Business Corporations Act (British Columbia) (the “BCBCA”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co., H.C. Wainwright & Co., LLC, Roth Capital Partners, LLC and A.G.P./Alliance Global Partners (collectively, the “Agents” and each individually an “Agent”), as follows:
Amended and Restated Sales AgreementSales Agreement • March 18th, 2020 • Acer Therapeutics Inc. • Pharmaceutical preparations • New York
Acer Therapeutics Inc., a Delaware corporation (the “Company”) and Roth Capital Partners, LLC (“Roth”) are parties to that certain Sales Agreement dated November 9, 2018 (the “Original Sales Agreement”). The Company and Roth, together with JonesTrading Institutional Services LLC (“JonesTrading” and together with Roth, the “Agents”) desire to amend and restate the Original Sales Agreement with this agreement (the “Agreement”), and hereby agree as follows:
CYTORI THERAPEUTICS, INC. SALES AGREEMENTSales Agreement • June 1st, 2018 • Cytori Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
AGENUS INC. Common Stock (par value 0.01) AT MARKET ISSUANCE SALES AGREEMENTSales Agreement • March 2nd, 2012 • Agenus Inc • Biological products, (no disgnostic substances) • New York
Agenus Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC, a Delaware limited liability company (“MLV” or the “Agent”), as follows:
